Quantcast
FDA Approves Contrave A New Drug To Battle Obesity

FDA Approves Contrave, A New Drug To Battle Obesity

John Hopton for redOrbit.com - Your Universe Online The Food and Drug Administration (FDA) has approved the weight loss pill Contrave, a medication that will be used to treat obese adults in conjunction with a controlled diet and exercise. It...

Latest Anorectics Stories

2014-09-15 08:29:16

PHILADELPHIA, September 15, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has accepted for filing with priority review a supplemental New Drug Application (sNDA) for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) as a treatment for adults with binge eating disorder (BED). The FDA is expected to provide a decision in February 2015, based on the...

2014-09-11 16:27:32

Colorado and Washington experience surges in marijuana tests positivity rate, but data suggests state legalization of recreational marijuana may not be sole driver of increases MADISON, N.J., Sept. 11, 2014 /PRNewswire/ -- The percentage of positive drug tests among American workers has increased for the first time in more than a decade, fueled by a rise in marijuana and amphetamines, according to an analysis of 8.5 million urine, oral fluid and hair workplace drug test results...

2014-09-11 08:27:41

New Medication for Obese Adults, or Overweight Adults with at Least One Weight-Related Comorbid Condition DEERFIELD, Ill., and LA JOLLA, Calif., Sept. 11, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. (Nasdaq: OREX) jointly announced today that the U.S. Food and Drug Administration (FDA) has approved Contrave® (naltrexone HCI and bupropion HCI) extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for...

2014-09-08 08:30:08

IADSA to Support ABC-AHP-NCNPR Botanical Adulterants Program, International Herbal Quality Control Initiative AUSTIN, Texas, Sept. 8, 2014 /PRNewswire-USNewswire/ -- The International Alliance of Dietary/Food Supplement Associations (IADSA) has endorsed the ABC-AHP-NCNPR Botanical Adulterants Program, an international consortium of nonprofit organizations, analytical laboratories, industry members, professional scientists, and others that advises industry, health professionals, and...

2014-09-02 08:29:50

- Patent Protection for NB32 for Treating Insulin Resistance - SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that the U.S. Patent and Trademark Office (PTO) has issued a patent related to NB32, the Company's investigational medication being evaluated for weight loss. NB32 is a fixed-dose combination of naltrexone sustained release (SR) and bupropion SR. U.S. Patent No. 8,815,889 claims methods for treating insulin resistance...

2014-08-30 23:02:07

The Firm is evaluating Byetta lawsuits on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer due to their use of the medication. New York, New York (PRWEB) August 30, 2014 Hundreds of Byetta lawsuits (http://www.byettalawsuit.com) and other incretin mimetic claims continue to move forward in U.S. courts, Bernstein Liebhard LLP reports. According to a statement issued by AstraZeneca PLC on July 31, 2014, Byetta and Bydureon (an extended-release...

2014-08-22 23:01:16

Cocaine and Teen Drug Abuse, A Guide Released Today By NoBullying http://nobullying.com/cocaine/ London, UK (PRWEB) August 22, 2014 Cocaine is a stimulant drug that is extremely addictive. It has been the drug of choice for many teens and youths. NoBullying releases today the guide to cocaine and teen drug abuse. Cocaine is extracted from coca leaves and was originally made to be a painkiller. One of the most serious ways to ingest cocaine is by injecting it. Cocaine is considered to be...

2014-08-20 16:25:28

Electronic Technology Blocks Illegal Sales, Allows Legal Ones LUTHERVILLE, Md., Aug. 20, 2014 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) today lauded the latest results achieved by the real-time, pseudoephedrine (PSE) blocking system in Missouri. The system, known as the National Precursor Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and helps law enforcement officials track down methamphetamine offenders and make...

2014-08-05 08:35:45

- Zalani joins Intarcia to drive the strategic and operational direction of Intarcia's Global Regulatory and Quality efforts with health authorities, partners and external stakeholders - BOSTON, Aug. 5, 2014 /PRNewswire/ -- Intarcia Therapeutics, Inc. today officially announced the appointment of Sunita Zalani, Ph.D., as Vice President and Global Head of Regulatory Affairs and Quality. In her new capacity, Dr. Zalani serves on the Leadership Team and reports directly to Chairman,...

2014-07-31 08:35:39

SAN DIEGO, July 31, 2014 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) will announce financial results for the second quarter 2014, on Thursday, August 7, 2014 before markets open. The announcement will be followed by a live webcast and conference call at 8:00 a.m. Eastern time (5:00 a.m. Pacific time). Orexigen management will host the call and webcast to discuss financial results and recent business highlights. The live call may be accessed by calling (800) 708-4540...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related